MedTrace Logo

Bone Marrow Concentrate (BMC) Injection in Intervertebral Discs

NCT04559295 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-09-22

No results posted yet for this study

Summary

Intradiscal delivery of bone marrow concentrate (BMC) into discs, facet, epidural space, and sacroiliac joints

Conditions

  • Low Back Pain
  • Disc Disease
  • Disc Degeneration
  • Arthropathy Vertebrae
  • Sacral Disorder
  • Radiculopathy
  • Spinal Stenosis

Interventions

BIOLOGICAL

Bone Marrow Concentrate

The intradiscal delivery of bone marrow concentrate (BMC) into discs, facet , epidural space, and sacroiliac joints

Sponsors & Collaborators

  • Stem Cures

    lead OTHER

Principal Investigators

  • Sairam Atluri, MD · Stem Cures

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-21
Primary Completion
2020-03-19
Completion
2021-04-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04559295 on ClinicalTrials.gov